| Literature DB >> 27798760 |
Bryana M Levitan1,2, Janet R Manning1,3, Catherine N Withers3, Jeffrey D Smith3, Robin M Shaw4, Douglas A Andres3, Vincent L Sorrell2, Jonathan Satin5.
Abstract
Sympathetic stimulation modulates L-type calcium channel (LTCC) gating to contribute to increased systolic heart function. Rad is a monomeric G-protein that interacts with LTCC. Genetic deletion of Rad (Rad-/-) renders LTCC in a sympathomimetic state. The study goal was to use a clinically inspired pharmacological stress echocardiography test, including analysis of global strain, to determine whether Rad-/- confers tonic positive inotropic heart function. Sarcomere dynamics and strain showed partial parallel isoproterenol (ISO) responsiveness for wild-type (WT) and for Rad-/-. Rad-/- basal inotropy was elevated compared to WT but was less responsiveness to ISO. Rad protein levels were lower in human patients with end-stage non-ischemic heart failure. These results show that Rad reduction provides a stable inotropic response rooted in sarcomere level function. Thus, reduced Rad levels in heart failure patients may be a compensatory response to need for increased output in the setting of HF. Rad deletion suggests a future therapeutic direction for inotropic support.Entities:
Keywords: Beta-adrenergic stimulation; Calcium; Calcium channel; Cell shortening; Echocardiography; Heart function
Mesh:
Substances:
Year: 2016 PMID: 27798760 PMCID: PMC5143207 DOI: 10.1007/s12265-016-9716-y
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132